Present possibilities and future development of clinical proteomics

被引:0
|
作者
Lehmann, S.
Dupuy, A.
Peoch, K.
Roche, S.
Baudin, B.
Quillard, M.
Berger, F.
Briand, G.
Chwetzoff, S.
Dine, G.
Gonzalo, P.
Dastugue, B.
Seve, M.
Siest, G.
Beaudeux, J. -L.
机构
[1] Hop St Antoine, Lab Biochim A, F-75571 Paris, France
[2] Grp Hosp Pitie Salpetriere, Serv Biochim Metab, F-75013 Paris, France
[3] CHU Albert Michallon, INSERM, Unite 318 Pavillon, Grenoble 9, France
[4] CHU Site Eurasante, Lab Biochim Biol Mol, F-59037 Lille, France
[5] CHU St Antoine, Fac Med, INSERM U, F-75012 Paris, France
[6] Fac Med, F-63001 Clermont Ferrand, France
[7] Ecole Cent Paris, Lab Ingn Biotechnol Sante, F-92295 Chatenay Malabry, France
[8] Hop Lapeyronie, Biochim Lab, F-34295 Montpellier 5, France
[9] Univ Lyon 1, Inst Biol Chim Prot, CNRS, UMR 5086,IFR 128, F-69367 Lyon, France
[10] Hop St Eloi, Biochim Lab, F-34295 Montpellier 5, France
[11] Hop Lariboisiere, Serv Biochim Biol Mol, F-75475 Paris 13, France
[12] CHU Rouen, Lab Biochim Med, F-76031 Rouen, France
[13] CHU Grenoble, Ctr Innovat Biol, F-38043 Grenoble, France
[14] UHP Nancy 1, Fac Pharm, INSERM, Equipe 4,U525, F-54000 Nancy, France
关键词
proteomics; multiplex; biomarker;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
This review focuses on "clinical proteomics" which represents an emerging discipline in biomedical research. "Clinical proteomics" relies on the analysis of the proteome, i.e. the entire set of peptides and proteins present in a biological sample, to provide relevant data for diagnosis, prognosis or therapeutic strategies of human pathologies. This new type of approach has tremendous potential for the diagnosis of complex pathologies or for the early detection of cancers. This article reports the conclusions of a workgroup of the French Society for Clinical Biology (SFBC) 2004-2006 which evaluated the status, the impact and the future development of proteomics in the clinical field. It provides therefore a broad view going from the methods already present in the clinical laboratories (multiplex technologies...), to the tools for clinical and basis research including bioinformatics.
引用
收藏
页码:463 / 471
页数:9
相关论文
共 50 条
  • [1] Clinical application of tear proteomics: Present and future prospects
    Wu, Kaili
    Zhang, Yanli
    [J]. PROTEOMICS CLINICAL APPLICATIONS, 2007, 1 (09) : 972 - 982
  • [2] Mass spectrometry in clinical proteomics - from the present to the future
    Palmblad, Magnus
    Tiss, Ali
    Cramer, Rainer
    [J]. PROTEOMICS CLINICAL APPLICATIONS, 2009, 3 (01) : 6 - 17
  • [3] Proteomics in clinical trials and practice - Present uses and future promise
    Azad, Nilofer S.
    Rasool, Nabila
    Annunziata, Christina M.
    Minasian, Lori
    Whiteley, Gordon
    Kohn, Elise C.
    [J]. MOLECULAR & CELLULAR PROTEOMICS, 2006, 5 (10) : 1819 - 1829
  • [4] PRESENT METHODS AND FUTURE POSSIBILITIES
    GOLDZIEH.JW
    [J]. JOURNAL OF REPRODUCTIVE MEDICINE, 1970, 5 (01) : 82 - &
  • [5] Present difficulties, future possibilities
    Woody, GE
    [J]. ADDICTION, 1996, 91 (02) : 226 - 228
  • [6] Cardiovascular proteomics - Past, present, and future
    White, Melanie Y.
    Van Eyk, Jennifer E.
    [J]. MOLECULAR DIAGNOSIS & THERAPY, 2007, 11 (02) : 83 - 95
  • [7] Spore proteomics: the past, present and the future
    Abhyankar, Wishwas
    de Koning, Leo J.
    Brul, Stanley
    de Koster, Chris G.
    [J]. FEMS MICROBIOLOGY LETTERS, 2014, 358 (02) : 137 - 144
  • [8] CLINICAL PHARMACOLOGY - PRESENT STATUS AND FUTURE DEVELOPMENT
    LASAGNA, L
    KROHN, PL
    MAYER, JE
    [J]. SCIENCE, 1966, 152 (3720) : 388 - &
  • [9] Serelaxin in clinical development: past, present and future
    Unemori, Elaine
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2017, 174 (10) : 921 - 932
  • [10] PRESENT STATE OF GAMMAGRAPHY AND FUTURE POSSIBILITIES
    RUBIO, AR
    [J]. ENERGIA NUCLEAR, 1967, 11 (48): : 309 - &